The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.
Abbott to acquire Exact Sciences for about $21B
The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.